Human adipose beiging in response to cold and mirabegron

The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown. We exposed lean and obese research participants to cold (3...

Full description

Saved in:
Bibliographic Details
Published inJCI insight Vol. 3; no. 15
Main Authors Finlin, Brian S., Memetimin, Hasiyet, Confides, Amy L., Kasza, Ildiko, Zhu, Beibei, Vekaria, Hemendra J., Harfmann, Brianna, Jones, Kelly A., Johnson, Zachary R., Westgate, Philip M., Alexander, Caroline M., Sullivan, Patrick G., Dupont-Versteegden, Esther E., Kern, Philip A.
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 09.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown. We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system. Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects. Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals. Clinicaltrials.gov NCT02596776, NCT02919176. NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).
AbstractList The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown. We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system. Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects. Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals. Clinicaltrials.gov NCT02596776, NCT02919176. NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).
The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.BACKGROUNDThe induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.METHODSWe exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.RESULTSCold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.CONCLUSIONCold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.Clinicaltrials.gov NCT02596776, NCT02919176.TRIAL REGISTRATIONClinicaltrials.gov NCT02596776, NCT02919176.NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).FUNDINGNIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).
BACKGROUND. The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown. METHODS. We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β 3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system. RESULTS. Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β 3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine 660 in obese subjects. CONCLUSION. Cold or β 3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals. TRIAL REGISTRATION. Clinicaltrials.gov NCT02596776, NCT02919176. FUNDING. NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998). Cold stimulates beige adipose formation equally in both lean and obese humans, and the beta3 agonist mirabegron treatment stimulates beiging in obese, insulin-resistant humans.
Author Westgate, Philip M.
Finlin, Brian S.
Kern, Philip A.
Zhu, Beibei
Harfmann, Brianna
Johnson, Zachary R.
Sullivan, Patrick G.
Alexander, Caroline M.
Kasza, Ildiko
Confides, Amy L.
Dupont-Versteegden, Esther E.
Memetimin, Hasiyet
Vekaria, Hemendra J.
Jones, Kelly A.
AuthorAffiliation 1 The Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and
3 McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA
5 Spinal Cord and Brain Injury Research Center, and
6 College of Public Health, University of Kentucky, Lexington, Kentucky, USA
2 Department of Rehabilitation Sciences, College of Health Sciences and Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA
4 Department of Neuroscience
AuthorAffiliation_xml – name: 3 McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA
– name: 1 The Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and
– name: 4 Department of Neuroscience
– name: 5 Spinal Cord and Brain Injury Research Center, and
– name: 6 College of Public Health, University of Kentucky, Lexington, Kentucky, USA
– name: 2 Department of Rehabilitation Sciences, College of Health Sciences and Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA
Author_xml – sequence: 1
  givenname: Brian S.
  surname: Finlin
  fullname: Finlin, Brian S.
– sequence: 2
  givenname: Hasiyet
  surname: Memetimin
  fullname: Memetimin, Hasiyet
– sequence: 3
  givenname: Amy L.
  surname: Confides
  fullname: Confides, Amy L.
– sequence: 4
  givenname: Ildiko
  surname: Kasza
  fullname: Kasza, Ildiko
– sequence: 5
  givenname: Beibei
  surname: Zhu
  fullname: Zhu, Beibei
– sequence: 6
  givenname: Hemendra J.
  surname: Vekaria
  fullname: Vekaria, Hemendra J.
– sequence: 7
  givenname: Brianna
  surname: Harfmann
  fullname: Harfmann, Brianna
– sequence: 8
  givenname: Kelly A.
  surname: Jones
  fullname: Jones, Kelly A.
– sequence: 9
  givenname: Zachary R.
  surname: Johnson
  fullname: Johnson, Zachary R.
– sequence: 10
  givenname: Philip M.
  surname: Westgate
  fullname: Westgate, Philip M.
– sequence: 11
  givenname: Caroline M.
  orcidid: 0000-0002-7830-8043
  surname: Alexander
  fullname: Alexander, Caroline M.
– sequence: 12
  givenname: Patrick G.
  surname: Sullivan
  fullname: Sullivan, Patrick G.
– sequence: 13
  givenname: Esther E.
  surname: Dupont-Versteegden
  fullname: Dupont-Versteegden, Esther E.
– sequence: 14
  givenname: Philip A.
  surname: Kern
  fullname: Kern, Philip A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30089732$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtLAzEQDlKxtfYPeJA9emnNYx_ZiyBFrVDwoueQx-w2ZTepyVbw37ultVQPnmaY-R7DfJdo4LwDhK4JnhFS0Lu1tjProq1X3YxQkhF8hkaUFeWUFZgPTvohmsS4xhiTIqU44xdoyDDmZcHoCPHFtpUukcZufIREga2tqxPrkgBx410_63yifWMS6UzS2iAV1MG7K3ReySbC5FDH6P3p8W2-mC5fn1_mD8upTjHtpszkqswYVRnFZZrTTHOpqwqYwsDTvMoNZwpAKpNDvyYEG6NowbRJgVNWsjG63-tutqoFo8F1QTZiE2wrw5fw0orfG2dXovafIie0JGQncHsQCP5jC7ETrY0amkY68NsoKOY5zSkjrIfenHodTX7e1QPoHqCDjzFAdYQQLHaxiD4WcYhF7GPpSfwPSdtOdtbv7rXNf9RvgK2WrA
CitedBy_id crossref_primary_10_1186_s40246_019_0239_x
crossref_primary_10_1074_jbc_REV119_007363
crossref_primary_10_1016_j_devcel_2022_11_007
crossref_primary_10_1016_j_lfs_2021_120229
crossref_primary_10_1016_j_heliyon_2022_e09128
crossref_primary_10_3390_metabo11050319
crossref_primary_10_1093_jmcb_mjaa029
crossref_primary_10_1097_MCO_0000000000000662
crossref_primary_10_1172_jci_insight_143650
crossref_primary_10_3390_ph14111196
crossref_primary_10_1210_clinem_dgz298
crossref_primary_10_1016_j_phrs_2023_106713
crossref_primary_10_7570_jomes20038
crossref_primary_10_3389_fendo_2022_898139
crossref_primary_10_1172_JCI134892
crossref_primary_10_1172_jci_insight_139160
crossref_primary_10_1177_23259671231170192
crossref_primary_10_3389_fphar_2024_1412520
crossref_primary_10_1016_j_stemcr_2021_01_013
crossref_primary_10_1038_s41467_023_38471_z
crossref_primary_10_1016_j_ejphar_2022_174870
crossref_primary_10_1152_ajpcell_00060_2024
crossref_primary_10_1210_endrev_bnac015
crossref_primary_10_1002_smll_202002872
crossref_primary_10_1016_j_cmet_2022_09_009
crossref_primary_10_1080_23328940_2020_1769530
crossref_primary_10_1186_s12986_022_00694_0
crossref_primary_10_1042_BSR20194076
crossref_primary_10_3390_ijms23094880
crossref_primary_10_1002_oby_24132
crossref_primary_10_1016_j_biopha_2025_117838
crossref_primary_10_1016_j_cell_2020_06_021
crossref_primary_10_1074_jbc_RA119_011508
crossref_primary_10_1038_s41366_023_01270_z
crossref_primary_10_1016_j_devcel_2021_02_018
crossref_primary_10_1172_JCI153357
crossref_primary_10_1249_MSS_0000000000003136
crossref_primary_10_3390_ijms252413295
crossref_primary_10_1002_mco2_207
crossref_primary_10_1172_JCI131126
crossref_primary_10_3390_nu12020472
crossref_primary_10_1007_s12272_021_01314_w
crossref_primary_10_1111_bph_14631
crossref_primary_10_1016_j_cmet_2020_07_005
crossref_primary_10_1016_j_bbrc_2023_03_052
crossref_primary_10_1038_s41598_021_03014_3
crossref_primary_10_1016_j_biopha_2019_109439
crossref_primary_10_3390_molecules29102219
crossref_primary_10_3390_ijms23094759
crossref_primary_10_1016_j_jconrel_2024_09_025
crossref_primary_10_1097_SHK_0000000000001743
crossref_primary_10_1016_j_phrs_2020_105291
crossref_primary_10_1302_2046_3758_128_BJR_2022_0309_R2
crossref_primary_10_3389_fendo_2022_1037458
crossref_primary_10_1016_j_mam_2019_06_006
crossref_primary_10_1038_s43587_024_00633_z
crossref_primary_10_1016_j_devcel_2024_03_012
crossref_primary_10_1016_j_mito_2021_05_001
crossref_primary_10_1093_function_zqac037
crossref_primary_10_1177_03000605221109391
crossref_primary_10_1007_s13679_024_00559_y
crossref_primary_10_3390_metabo10110471
crossref_primary_10_4093_dmj_2023_0011
crossref_primary_10_1146_annurev_physiol_060721_092939
crossref_primary_10_3390_jcm12216897
crossref_primary_10_1038_s41598_019_45136_9
crossref_primary_10_1007_s00266_023_03782_5
crossref_primary_10_3389_jpps_2024_13157
crossref_primary_10_1186_s10020_020_00180_4
crossref_primary_10_1002_stem_3164
crossref_primary_10_1016_j_metabol_2025_156148
crossref_primary_10_1152_ajpendo_00259_2022
crossref_primary_10_18705_2782_3806_2025_5_1_6_28
crossref_primary_10_3389_fnins_2021_621356
crossref_primary_10_1093_cvr_cvac131
crossref_primary_10_1016_j_ando_2024_05_006
crossref_primary_10_3390_cells12060881
crossref_primary_10_2139_ssrn_4119814
crossref_primary_10_3389_fcell_2022_955612
crossref_primary_10_1073_pnas_1901655116
crossref_primary_10_1016_j_jep_2022_115700
crossref_primary_10_1038_s41467_024_46944_y
crossref_primary_10_1093_asj_sjae070
crossref_primary_10_3389_fendo_2021_652444
crossref_primary_10_1016_j_phrs_2022_106634
crossref_primary_10_1002_mnfr_202000681
crossref_primary_10_1007_s42000_022_00361_2
crossref_primary_10_1001_jamacardio_2023_3003
crossref_primary_10_1096_fj_202101905RR
crossref_primary_10_1371_journal_pbio_3002413
crossref_primary_10_1080_17512433_2023_2193681
crossref_primary_10_3390_biom14020159
crossref_primary_10_1016_j_molmet_2023_101683
crossref_primary_10_18632_aging_206203
crossref_primary_10_1002_oby_23496
crossref_primary_10_1111_apha_14127
crossref_primary_10_1016_j_devcel_2021_04_018
crossref_primary_10_1111_febs_15470
crossref_primary_10_1016_j_mmm_2021_10_017
crossref_primary_10_29219_fnr_v65_7577
crossref_primary_10_1530_JOE_18_0598
crossref_primary_10_3390_biom13121714
crossref_primary_10_3390_ijms22137050
crossref_primary_10_1002_mco2_70030
crossref_primary_10_1038_s41598_020_78419_7
crossref_primary_10_3390_ijms23031869
crossref_primary_10_1038_s42255_023_00837_4
crossref_primary_10_3390_cells9122584
crossref_primary_10_1038_s41574_020_0390_4
crossref_primary_10_1016_j_metabol_2024_155998
crossref_primary_10_1111_cpf_12896
crossref_primary_10_1113_JP280922
crossref_primary_10_1038_s41580_021_00350_0
crossref_primary_10_3389_fphys_2023_1132830
crossref_primary_10_1152_ajpendo_00310_2020
crossref_primary_10_1016_j_mam_2019_07_001
crossref_primary_10_1042_CS20190522
crossref_primary_10_3390_cancers14081948
crossref_primary_10_1016_j_biopha_2021_111491
crossref_primary_10_5534_wjmh_220224
crossref_primary_10_1111_dom_15781
crossref_primary_10_1161_ATVBAHA_121_315882
crossref_primary_10_1038_s41598_020_64369_7
crossref_primary_10_3389_fped_2024_1401737
crossref_primary_10_1002_ctm2_1108
crossref_primary_10_3389_fendo_2019_00368
crossref_primary_10_1007_s10522_024_10137_3
crossref_primary_10_1016_j_hsr_2024_100148
crossref_primary_10_1124_jpet_118_255778
crossref_primary_10_3389_fendo_2020_00222
crossref_primary_10_1111_1440_1681_13566
crossref_primary_10_3389_fphys_2020_00749
crossref_primary_10_1073_pnas_2205626119
crossref_primary_10_2217_epi_2023_0381
crossref_primary_10_1080_27697061_2023_2280777
crossref_primary_10_1002_mco2_752
crossref_primary_10_33549_physiolres_935361
crossref_primary_10_1016_j_gene_2024_148421
Cites_doi 10.2337/db09-0530
10.1007/s00192-013-2042-x
10.1155/2015/341583
10.1002/ana.20062
10.1038/nm.4031
10.3389/fendo.2015.00156
10.1016/j.cell.2013.12.021
10.1152/japplphysiol.00096.2017
10.1016/j.cmet.2011.06.012
10.1016/S2213-8587(14)70033-6
10.1172/JCI62308
10.1074/jbc.M305235200
10.1210/js.2017-00202
10.1016/0895-7061(96)87747-8
10.1038/ijo.2013.206
10.1016/j.cmet.2012.01.004
10.1016/j.cmet.2016.10.023
10.1016/j.bbalip.2013.02.005
10.1038/oby.2011.125
10.1016/j.tem.2012.06.004
10.1016/j.tips.2013.04.004
10.1080/21623945.2016.1191307
10.1016/j.cmet.2008.12.014
10.1089/neu.2006.3673
10.1038/366740a0
10.1172/JCI60433
10.1172/JCI78362
10.1038/nature17399
10.1002/ana.10543
10.1152/ajpendo.00298.2010
10.1210/jc.2006-1740
10.1016/j.molmet.2015.07.001
10.1016/j.cmet.2013.02.020
10.1056/NEJMoa0808718
10.1152/ajpendo.00329.2010
10.1074/jbc.M115.637785
10.1111/ijcp.12433
10.1016/0026-0495(89)90118-2
10.1016/j.cmet.2015.06.022
10.1016/j.cmet.2014.12.009
10.2337/diabetes.47.10.1555
10.2337/db14-0746
10.1038/nature13528
10.1016/j.cell.2012.05.016
10.1038/nm.3891
10.1152/ajpendo.00284.2016
10.1016/0076-6879(79)55010-1
10.2337/diabetes.54.8.2305
10.1016/S0014-2999(02)01421-8
10.1073/pnas.1310261110
10.1016/j.ecl.2004.03.002
10.1016/j.cmet.2015.09.007
10.1056/NEJMoa0810780
10.2337/db10-0004
10.1038/281031a0
10.1210/jc.2014-2440
10.1113/expphysiol.2014.081414
10.1128/MCB.24.7.3057-3067.2004
10.2337/db16-1057
10.1073/pnas.1207287109
10.1016/j.cmet.2014.06.011
ContentType Journal Article
Copyright Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation
Copyright_xml – notice: Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1172/jci.insight.121510
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2379-3708
ExternalDocumentID PMC6129119
30089732
10_1172_jci_insight_121510
Genre Video-Audio Media
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GrantInformation NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P30 GM127211
– fundername: NIGMS NIH HHS
  grantid: P20 GM103527
– fundername: NIDDK NIH HHS
  grantid: R01 DK112282
– fundername: NCATS NIH HHS
  grantid: UL1 TR001998
– fundername: NIDDK NIH HHS
  grantid: R01 DK107646
GroupedDBID 53G
AAFWJ
AAYXX
ADBBV
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
CITATION
GROUPED_DOAJ
HYE
M~E
OK1
RPM
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c402t-3d6b9532b52094625c8acffe3b0e846f6d83beeabd6e462110ddb273cd4e82393
ISSN 2379-3708
IngestDate Thu Aug 21 13:27:40 EDT 2025
Fri Jul 11 06:47:14 EDT 2025
Thu Jan 02 22:59:36 EST 2025
Tue Jul 01 02:59:22 EDT 2025
Thu Apr 24 23:08:05 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Keywords Obesity
Adipose tissue
Metabolism
Clinical Trials
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c402t-3d6b9532b52094625c8acffe3b0e846f6d83beeabd6e462110ddb273cd4e82393
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Authorship note: BSF, HM, and ALC contributed equally to this work.
ORCID 0000-0002-7830-8043
OpenAccessLink http://insight.jci.org/articles/view/121510/files/pdf
PMID 30089732
PQID 2086262313
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6129119
proquest_miscellaneous_2086262313
pubmed_primary_30089732
crossref_primary_10_1172_jci_insight_121510
crossref_citationtrail_10_1172_jci_insight_121510
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-8-9
2018-08-09
20180809
PublicationDateYYYYMMDD 2018-08-09
PublicationDate_xml – month: 08
  year: 2018
  text: 2018-8-9
  day: 09
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JCI insight
PublicationTitleAlternate JCI Insight
PublicationYear 2018
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B21
B22
B23
B24
B25
B27
B28
B29
Thorp (B36) 2015; 2015
B30
B31
B32
B33
B34
Cannon (B58) 1979; 55
B35
B37
B39
B1
B2
B3
B4
B5
B6
Porter (B7) 2015; 6
B8
B9
Frontini (B26) 2013; 1831
B40
B41
B42
B43
B44
B45
B46
B47
B48
B49
Facchini (B38) 1996; 9
B50
B51
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B15
B59
B16
B17
B18
B19
B60
B61
References_xml – ident: B22
  doi: 10.2337/db09-0530
– ident: B54
  doi: 10.1007/s00192-013-2042-x
– volume: 2015
  year: 2015
  ident: B36
  article-title: Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
  publication-title: J Diabetes Res
  doi: 10.1155/2015/341583
– ident: B61
  doi: 10.1002/ana.20062
– ident: B15
  doi: 10.1038/nm.4031
– volume: 6
  year: 2015
  ident: B7
  article-title: The Therapeutic Potential of Brown Adipocytes in Humans
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2015.00156
– ident: B9
  doi: 10.1016/j.cell.2013.12.021
– ident: B32
  doi: 10.1152/japplphysiol.00096.2017
– ident: B11
  doi: 10.1016/j.cmet.2011.06.012
– ident: B35
  doi: 10.1016/S2213-8587(14)70033-6
– ident: B8
  doi: 10.1172/JCI62308
– ident: B29
  doi: 10.1074/jbc.M305235200
– ident: B57
  doi: 10.1210/js.2017-00202
– volume: 9
  start-page: 1013
  issue: 10 Pt 1
  year: 1996
  ident: B38
  article-title: Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate
  publication-title: Am J Hypertens
  doi: 10.1016/0895-7061(96)87747-8
– ident: B12
  doi: 10.1038/ijo.2013.206
– ident: B16
  doi: 10.1016/j.cmet.2012.01.004
– ident: B42
  doi: 10.1016/j.cmet.2016.10.023
– volume: 1831
  start-page: 950
  issue: 5
  year: 2013
  ident: B26
  article-title: White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbalip.2013.02.005
– ident: B40
  doi: 10.1038/oby.2011.125
– ident: B45
  doi: 10.1016/j.tem.2012.06.004
– ident: B49
  doi: 10.1016/j.tips.2013.04.004
– ident: B23
  doi: 10.1080/21623945.2016.1191307
– ident: B6
  doi: 10.1016/j.cmet.2008.12.014
– ident: B59
  doi: 10.1089/neu.2006.3673
– ident: B5
  doi: 10.1038/366740a0
– ident: B13
  doi: 10.1172/JCI60433
– ident: B3
  doi: 10.1172/JCI78362
– ident: B43
  doi: 10.1038/nature17399
– ident: B60
  doi: 10.1002/ana.10543
– ident: B14
  doi: 10.1152/ajpendo.00298.2010
– ident: B50
  doi: 10.1210/jc.2006-1740
– ident: B47
  doi: 10.1016/j.molmet.2015.07.001
– ident: B48
  doi: 10.1016/j.cmet.2013.02.020
– ident: B21
  doi: 10.1056/NEJMoa0808718
– ident: B55
  doi: 10.1152/ajpendo.00329.2010
– ident: B34
  doi: 10.1074/jbc.M115.637785
– ident: B53
  doi: 10.1111/ijcp.12433
– ident: B39
  doi: 10.1016/0026-0495(89)90118-2
– ident: B24
  doi: 10.1016/j.cmet.2015.06.022
– ident: B28
  doi: 10.1016/j.cmet.2014.12.009
– ident: B52
  doi: 10.2337/diabetes.47.10.1555
– ident: B10
  doi: 10.2337/db14-0746
– ident: B27
  doi: 10.1038/nature13528
– ident: B2
  doi: 10.1016/j.cell.2012.05.016
– ident: B17
  doi: 10.1038/nm.3891
– ident: B44
  doi: 10.1152/ajpendo.00284.2016
– volume: 55
  start-page: 65
  year: 1979
  ident: B58
  article-title: Mitochondria from brown adipose tissue: isolation and properties
  publication-title: Meth Enzymol
  doi: 10.1016/0076-6879(79)55010-1
– ident: B56
  doi: 10.2337/diabetes.54.8.2305
– ident: B51
  doi: 10.1016/S0014-2999(02)01421-8
– ident: B33
  doi: 10.1073/pnas.1310261110
– ident: B37
  doi: 10.1016/j.ecl.2004.03.002
– ident: B1
  doi: 10.1016/j.cmet.2015.09.007
– ident: B20
  doi: 10.1056/NEJMoa0810780
– ident: B41
  doi: 10.2337/db10-0004
– ident: B4
  doi: 10.1038/281031a0
– ident: B19
  doi: 10.1210/jc.2014-2440
– ident: B46
  doi: 10.1113/expphysiol.2014.081414
– ident: B31
  doi: 10.1128/MCB.24.7.3057-3067.2004
– ident: B18
  doi: 10.2337/db16-1057
– ident: B30
  doi: 10.1073/pnas.1207287109
– ident: B25
  doi: 10.1016/j.cmet.2014.06.011
SSID ssj0001742058
Score 2.4590836
Snippet The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The...
BACKGROUND. The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Acetanilides - pharmacology
Acetanilides - therapeutic use
Adipose Tissue, Beige - drug effects
Adipose Tissue, Beige - metabolism
Adipose Tissue, Beige - pathology
Adrenergic beta-3 Receptor Agonists - pharmacology
Adrenergic beta-3 Receptor Agonists - therapeutic use
Adult
Biopsy
Clinical Medicine
Cold Temperature - adverse effects
Energy Metabolism - drug effects
Energy Metabolism - physiology
Female
Humans
Lipid Metabolism - drug effects
Lipid Metabolism - physiology
Male
Membrane Proteins - metabolism
Middle Aged
Obesity - drug therapy
Obesity - metabolism
Obesity - pathology
Subcutaneous Fat - drug effects
Subcutaneous Fat - metabolism
Subcutaneous Fat - pathology
Thermogenesis - physiology
Thiazoles - pharmacology
Thiazoles - therapeutic use
Uncoupling Protein 1 - metabolism
Title Human adipose beiging in response to cold and mirabegron
URI https://www.ncbi.nlm.nih.gov/pubmed/30089732
https://www.proquest.com/docview/2086262313
https://pubmed.ncbi.nlm.nih.gov/PMC6129119
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFLc6dtllGtpXGUyetFuVLrGdjx4RYoIxdgKJW-SvMG80RW16gAN_O8-O46bQTWOXqHJiy_Xv5fn3nPeB0Oc0kVSxjEYyjRkYKDqPBEt4RCSpiKoSnlAb73z6Izs6Z98u0ovB4KTntbRsxFjebowr-R9UoQ1wtVGyT0A2DAoN8BvwhSsgDNd_wrg9gefKXFuvc6HNZYhQcZ6vriwGIO3SsY6mZs6Fvpx7IDpGenBsHdKtjR6wNHVXxn3u3v9xgEVPdWPrgLkdiy_MzSp-2sYOGtVqnf3pzeh76HXCF7eOox5fKfN71j9oSArn5jZZ6SNC8wnoo7hVl3pDm1eotC836WY9ndu8r7-kGft_6LJceAfXtaTYDzar4ELojJeclDBG6cco2zGeoecEbAZbzuL0rnfgljMSu3qtYdJdEFVOvjyeyjpReWR9PHSi7bGSs1fopTcn8H4rG9tooOvXqHBygb1cYC8X2NS4kwvczLCVCwxygVdy8Qadfz08OziKfIWMSILd30RUZWKSUiKsMxMDU1YWXFaVpiLWQCyrTBVUaM2FyjTcBqqnlADCKhXThU1-9xZt1bNav0e4YtCBFyJWccGgC2d5JbTimUiKXKt4iJJuOUrp08fbKiZX5Z-RGKJR6HPdJk_569OfulUuQcfZD1e81rPloiTO7gZLhA7Ru3bVw3gUSKzNODVE-Roe4QGbP339Tm1-ujzqQO5hq5_sPGmWH9CL1cuxi7aa-VLvAS9txEcnb_dY8pKB
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+adipose+beiging+in+response+to+cold+and+mirabegron&rft.jtitle=JCI+insight&rft.au=Finlin%2C+Brian+S.&rft.au=Memetimin%2C+Hasiyet&rft.au=Confides%2C+Amy+L.&rft.au=Kasza%2C+Ildiko&rft.date=2018-08-09&rft.issn=2379-3708&rft.eissn=2379-3708&rft.volume=3&rft.issue=15&rft_id=info:doi/10.1172%2Fjci.insight.121510&rft.externalDBID=n%2Fa&rft.externalDocID=10_1172_jci_insight_121510
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-3708&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-3708&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-3708&client=summon